MAP2K4 — Mitogen-Activated Protein Kinase Kinase 4

MAP2K4 — Mitogen-Activated Protein Kinase Kinase 4

Introduction

MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4), also known as MKK4 or JNKK1, is a dual-specificity protein kinase that serves as a critical node in cellular stress signaling. It phosphorylates and activates both the JNK (c-Jun N-terminal kinase) and p38 MAPK pathways, making it a central regulator of stress responses, apoptosis, and cell survival in the brain[@davis2022].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">MAP2K4 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>MAP2K4</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>MKK4, JNKK1, MEK4, SKK4</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitogen-Activated Protein Kinase Kinase 4</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>17p12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[5606](https://www.ncbi.nlm.nih.gov/gene/5606)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P45985](https://www.uniprot.org/uniprot/P45985)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000157873</td></tr>
<tr><td><strong>Protein Size</strong></td><td>399 amino acids</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Protein Structure and Function

Kinase Domain Architecture

MAP2K4 — Mitogen-Activated Protein Kinase Kinase 4

Introduction

MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4), also known as MKK4 or JNKK1, is a dual-specificity protein kinase that serves as a critical node in cellular stress signaling. It phosphorylates and activates both the JNK (c-Jun N-terminal kinase) and p38 MAPK pathways, making it a central regulator of stress responses, apoptosis, and cell survival in the brain[@davis2022].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">MAP2K4 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>MAP2K4</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>MKK4, JNKK1, MEK4, SKK4</td></tr>
<tr><td><strong>Full Name</strong></td><td>Mitogen-Activated Protein Kinase Kinase 4</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>17p12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[5606](https://www.ncbi.nlm.nih.gov/gene/5606)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P45985](https://www.uniprot.org/uniprot/P45985)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000157873</td></tr>
<tr><td><strong>Protein Size</strong></td><td>399 amino acids</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Protein Structure and Function

Kinase Domain Architecture

MAP2K4 contains:

• N-terminal docking domain: For interaction with substrates and upstream kinases
• Kinase domain: Catalytic core with dual-specificity
• C-terminal regulatory region: Contains serine/threonine residues for activation

Catalytic Activity

As a dual-specificity kinase, MAP2K4:

| Substrate | Activation Site | Downstream Effect |
|-----------|-----------------|-------------------|
| JNK1/2/3 | Thr183/Tyr185 | AP-1 activation, apoptosis |
| p38α/β | Thr180/Tyr182 | Inflammation, stress response |

Activation Mechanism

MAP2K4 is activated by:

Structural Features

The MAP2K4 protein contains several key structural features[@gavron2019]:

• N-terminal D-domain: Conserved docking motif for interaction with upstream MAP3Ks and downstream MAPK substrates
• Kinase domain (aa 80-330): Contains the catalytic core with the dual-specificity activity
• Activation loop: Contains the critical S222 and S228 phosphorylation sites
• C-terminal regulatory region: Modulates interaction with scaffolds and localization

Signaling Pathways

MAP2K4/JNK/p38 Cascade

Cellular Functions

| Function | Pathway | Outcome |
|----------|---------|---------|
| Stress Response | p38 | Cytokine production, cell adaptation |
| Apoptosis | JNK | Pro-apoptotic signaling in neurons |
| Inflammation | p38 | Neuroinflammatory responses |
| Synaptic Plasticity | JNK | Excitotoxicity, memory impairment |

Expression Patterns

Brain Distribution

• Hippocampus: High expression in CA1-CA3 and dentate gyrus
• Cortex: All layers, particularly layers II-III and V
• Cerebellum: Purkinje cells and granule cells
• Substantia Nigra: Dopaminergic neurons

Cellular Localization

• Neurons: Cytoplasmic and nuclear compartments
• Astrocytes: Induced under stress conditions
• Microglia: Activated state expression

Role in Neurodegeneration

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease)[@kim2021]:

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease)[@morel2020]:

Amyotrophic Lateral Sclerosis

• Motor Neuron Degeneration: MAP2K4/JNK pathway activated in ALS models
• Excitotoxicity: Contributes to glutamate-induced motor neuron death
• Therapeutic Target: JNK inhibitors show promise in preclinical models

Stroke and Brain Injury

• Ischemic Damage: Strong activation of JNK pathway following stroke
• Neuroprotection: MAP2K4 inhibition reduces infarct size in models
• Therapeutic Window: Potential for intervention post-stroke

Therapeutic Implications

Drug Development

| Approach | Status | Target |
|----------|--------|--------|
| JNK Inhibitors | Clinical trials | c-Jun, JNK pathway |
| p38 Inhibitors | Clinical trials | Inflammatory responses |
| MAP2K4 Modulators | Preclinical | Pathway activation |

Biomarkers

• Phospho-JNK levels: Potential marker for neuronal stress
• MAP2K4 activity: Could indicate disease progression

Research Directions

Interactions

| Interactor | Type | Relationship |
|------------|------|--------------|
| MAP3K1-4 | Kinase | Upstream activators |
| JNK1/2/3 | Kinase | Substrate |
| p38α/β | Kinase | Substrate |
| JIP1/2/3 | Scaffold | Localization |
| ATF2 | Transcription factor | Downstream target |

JNK and p38 Isoform Specificity

MAP2K4 exhibits differential activation of MAPK isoforms:

| MAP2K4 Activity | JNK Isoforms | p38 Isoforms | Physiological Outcome |
|-----------------|--------------|--------------|----------------------|
| High | JNK1/JNK2 | p38α | Strong pro-apoptotic signaling |
| Moderate | JNK3 | p38β | Tissue-specific effects |
| Low | JNK1/2 | p38γ/δ | Stress adaptation |

Negative Regulation

MAP2K4 activity is negatively regulated by:

• MAPK phosphatases (MKPs): DUSP1, DUSP2, DUSP10 dephosphorylate MAP2K4
• Inhibitory phosphorylation: Serine/threonine phosphatases reverse activation
• Protein inhibitors: Specific protein inhibitors of MAP2K4

Therapeutic Implications

Drug Development

| Approach | Status | Target |
|----------|--------|--------|
| JNK Inhibitors | Clinical trials | c-Jun, JNK pathway |
| p38 Inhibitors | Clinical trials | Inflammatory responses |
| MAP2K4 Modulators | Preclinical | Pathway activation |
| Dual JNK/p38 Inhibitors | Preclinical | Broader pathway inhibition |

Biomarkers

• Phospho-JNK levels: Potential marker for neuronal stress
• MAP2K4 activity: Could indicate disease progression
• Phospho-p38: Inflammatory biomarker

Research Directions

See Also

• [JNK Signaling Pathway](/mechanisms/jnk-signaling)
• [p38 MAPK Pathway](/mechanisms/p38-mapk-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Apoptosis Pathways](/mechanisms/apoptosis-pathways)
• [Neurodegeneration](/diseases/neurodegeneration)
• [Stress Response Pathways](/mechanisms/cellular-stress-response)

References